The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network-Reference-Cited by-同舟云学术

The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network

Published:2021-03 Issue:2 Volume:20 Page:195-197
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Pearson Kelsie^ORCID,Mayer-Hamblett Nicole,Goss Christopher H.,Retsch-Bogart George Z.,VanDalfsen Jill M.,Burks Patricia^ORCID,Rosenbluth Daniel,Clancy John Paul,Hoffman Amy,Nichols David P.

Funder

Foundation for the National Institutes of Health

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Reference7 articles.

1. Impact of COVID-19 on oncology clinical trials;Upadhaya;Nat Rev Drug Discov,2020

2. The impact of COVID-19 on dermatology clinical trials;Desai;J Invest Dermatol,2020

3. SARS-CoV-2 disrupts clinical research: the role of a rare disease-specific trial network;van Koningsbruggen-Rietschel;Eur Respir J,2020

4. A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis;Cosgriff;J Cyst Fibros,2020

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal improvements in clinical and functional outcomes following initiation of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis;Heliyon;2024-04

2. Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases;Archivos de Bronconeumología;2022-04

3. From the Editor's Desk;Journal of Cystic Fibrosis;2022-03

4. A year in review: Real world evidence, functional monitoring and emerging therapeutics in 2021;Journal of Cystic Fibrosis;2022-03

5. Home monitoring for cystic fibrosis: The future is now;Journal of Cystic Fibrosis;2022-01